These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 1136972)
1. Editorial: Solving problems associated with large-volume parenterals. I: pharmacist responsibility for compounding intravenous admixtures. Zellmer WA Am J Hosp Pharm; 1975 Mar; 32(3):255. PubMed ID: 1136972 [No Abstract] [Full Text] [Related]
2. Recommendations to pharmacists for solving problems with large-volume parenterals. Am J Hosp Pharm; 1976 Mar; 33(3):231-6. PubMed ID: 816199 [No Abstract] [Full Text] [Related]
3. Recommended methods for compounding intravenous admixtures in hospitals. Am J Hosp Pharm; 1975 Mar; 32(3):261-70. PubMed ID: 1136973 [TBL] [Abstract][Full Text] [Related]
4. Pharmacists' opinions about and compliance with recommendations for intravenous admixture practices. Brzozowski DF; Hale KM; Segal R; Mirtallo JM Am J Hosp Pharm; 1987 Sep; 44(9):2077-84. PubMed ID: 3479020 [TBL] [Abstract][Full Text] [Related]
5. Recommendations to pharmacists for solving problems with large-volume parenterals-1979. National Coordinating Committee on Large Volume Parenterals. Am J Hosp Pharm; 1980 May; 37(5):663-7. PubMed ID: 7386474 [No Abstract] [Full Text] [Related]
6. Pharmacist should police IV additive practices. Bowles GC Mod Hosp; 1968 Aug; 111(2):96. PubMed ID: 5713980 [No Abstract] [Full Text] [Related]
7. Recommended system for surveillance and reporting of problems with large-volume parenterals in hospitals. Am J Hosp Pharm; 1975 Dec; 32(12):1251-3. PubMed ID: 1211398 [TBL] [Abstract][Full Text] [Related]
8. Stability issues of parenteral chemotherapy drugs. de Lemos ML; Hamata L J Oncol Pharm Pract; 2007 Mar; 13(1):27-31. PubMed ID: 17621564 [TBL] [Abstract][Full Text] [Related]
9. Intravenous solution manual and incompatibility file; its use in a community hospital. Donn R Am J Hosp Pharm; 1967 Aug; 24(8):459-61. PubMed ID: 6075731 [No Abstract] [Full Text] [Related]
10. Intravenous admixture training program for pharmacy personnel. Hunt ML Am J Hosp Pharm; 1974 May; 31(5):467-71. PubMed ID: 4829388 [No Abstract] [Full Text] [Related]
11. ASHP technical assistance bulletin on compounding nonsterile products in pharmacies. American Society of Hospital Pharmacists. Am J Hosp Pharm; 1994 Jun; 51(11):1441-8. PubMed ID: 7942879 [No Abstract] [Full Text] [Related]
12. National survey of selected hospital pharmacy practices. Stolar MH Am J Hosp Pharm; 1976 Mar; 33(3):225-30. PubMed ID: 1258882 [TBL] [Abstract][Full Text] [Related]
14. Recommended guidelines for quality assurance in hospital centralized intravenous admixture services. National Coordinating Committee on Large Volume Parenterals. Am J Hosp Pharm; 1980 May; 37(5):645-55. PubMed ID: 7386471 [TBL] [Abstract][Full Text] [Related]
15. Training personnel for intravenous admixture programs. Hinshaw WR; Wilken LO Am J Hosp Pharm; 1972 Dec; 29(12):1025-9. PubMed ID: 4646700 [No Abstract] [Full Text] [Related]
16. Personnel costs and preparation time in a centralized intravenous admixture program. Ryan DM; Daniels CE; Somani SM Am J Hosp Pharm; 1986 May; 43(5):1222-5. PubMed ID: 3087164 [TBL] [Abstract][Full Text] [Related]
17. I.V. additives move to the pharmacy. Peritore SP; Rosenberg JM Hospitals; 1971 Dec; 45(24):84-91. PubMed ID: 5135288 [No Abstract] [Full Text] [Related]
18. Unsafe activities of compounding pharmacists. Perrin JH Am J Health Syst Pharm; 1995 Dec; 52(24):2827-8. PubMed ID: 8748571 [No Abstract] [Full Text] [Related]
19. Editorial: Solving problems associated with large-volume parenterals, II: A hospital surveillance and reporting system. Zellmer WA Am J Hosp Pharm; 1975 Dec; 32(12):1231. PubMed ID: 1211394 [No Abstract] [Full Text] [Related]